Group 1 - Aladdin plans to acquire a 35% stake in Shanghai Youke for 61.25 million yuan, which will make Shanghai Youke an associate company of Aladdin after the transaction [1] - The funding for the acquisition will come from Aladdin's own or raised funds, with a cash balance of 613 million yuan as of Q3 2025 and a net cash flow from operating activities of 159 million yuan for the first three quarters [1] - Shanghai Youke specializes in the R&D, production, sales, and service of general laboratory analytical instruments, with key products including UV-visible spectrophotometers and high-precision laboratory electronic balances [1][2] Group 2 - The acquisition aligns with Aladdin's core business in research reagents, allowing for synergistic opportunities such as bundled sales of instruments and reagents, enhancing customer retention [2] - Shanghai Youke's projected revenue and net profit for 2024 are 102 million yuan and 22.48 million yuan, respectively, with total assets of 162 million yuan and net assets of 95.88 million yuan at the end of 2024 [2] - The estimated valuation of Shanghai Youke's 100% equity is 175 million yuan, reflecting an 82.51% increase in net assets as of the end of 2024 [2] Group 3 - Aladdin has been actively pursuing investments and partnerships to expand its product line and business chain, completing six investment projects since 2023 [3] - The company reported a revenue of 169 million yuan for Q3 2025, a year-on-year increase of 21.26%, and a net profit of 29.30 million yuan, up 15.8% [3] - The domestic market for research reagents is experiencing accelerated competition due to the rapid improvement in the quality and variety of domestic products, enhancing the competitiveness of local manufacturers [3]
阿拉丁拟6125万元购买上海佑科35%股权， 持续丰富公司产品线